12:00 AM
Oct 29, 2012
 |  BC Week In Review  |  Company News  |  Other News

Complete Genomics, Illumina genomics news

The U.S. District Court for the Northern District of California granted a partial summary judgment to Complete Genomics invalidating a number of claims in Illumina's U.S. Patent No. 6,306,597 covering DNA sequencing by parallel oligonucleotide extensions. The court said the claims are invalid due to prior art. Complete Genomics said it...

Read the full 232 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >